IL146458A0 - Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia - Google Patents
Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementiaInfo
- Publication number
- IL146458A0 IL146458A0 IL14645800A IL14645800A IL146458A0 IL 146458 A0 IL146458 A0 IL 146458A0 IL 14645800 A IL14645800 A IL 14645800A IL 14645800 A IL14645800 A IL 14645800A IL 146458 A0 IL146458 A0 IL 146458A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- senile dementia
- glycosaminoglycans
- molecular weight
- average molecular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI001066A IT1312107B1 (it) | 1999-05-14 | 1999-05-14 | Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile |
PCT/EP2000/004311 WO2000069444A1 (en) | 1999-05-14 | 2000-05-12 | Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146458A0 true IL146458A0 (en) | 2002-07-25 |
Family
ID=11382970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14645800A IL146458A0 (en) | 1999-05-14 | 2000-05-12 | Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia |
Country Status (22)
Country | Link |
---|---|
US (1) | US6979680B1 (cs) |
EP (1) | EP1181024B1 (cs) |
JP (1) | JP2002544233A (cs) |
KR (1) | KR100711142B1 (cs) |
CN (1) | CN1178667C (cs) |
AT (1) | ATE288761T1 (cs) |
AU (1) | AU764743C (cs) |
CA (1) | CA2373975A1 (cs) |
CZ (1) | CZ20014092A3 (cs) |
DE (1) | DE60018061T2 (cs) |
DK (1) | DK1181024T3 (cs) |
ES (1) | ES2237425T3 (cs) |
HK (1) | HK1039903B (cs) |
HU (1) | HUP0201100A3 (cs) |
IL (1) | IL146458A0 (cs) |
IT (1) | IT1312107B1 (cs) |
NO (1) | NO328902B1 (cs) |
PL (1) | PL198016B1 (cs) |
PT (1) | PT1181024E (cs) |
RU (1) | RU2248800C2 (cs) |
WO (1) | WO2000069444A1 (cs) |
ZA (1) | ZA200109331B (cs) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1344781A1 (en) * | 2002-03-12 | 2003-09-17 | Laboratori Derivati Organici S.P.A. | Process for the depolymerization of glycosaminoglycanes and products obtained therefrom |
ITMI20031023A1 (it) * | 2003-05-21 | 2004-11-22 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
EP1524276A1 (en) * | 2003-10-16 | 2005-04-20 | Laboratori Derivati Organici S.P.A. | Multistep process for the physical depolymerization of heparin and products obtained therefrom |
US7939512B2 (en) | 2004-10-13 | 2011-05-10 | Laboratori Derivati Organici Spa | Multistep process for the physical depolymerization of heparin and products obtained therefrom |
ES2352801T3 (es) | 2005-12-22 | 2011-02-23 | Kiacta Sàrl | Tratamiento de nefropatía diabética. |
WO2009007224A1 (en) * | 2007-07-10 | 2009-01-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Low molecular weight heparin derivatives having neuroprotective activity |
US8896239B2 (en) | 2008-05-22 | 2014-11-25 | Vladimir Yegorovich Balakin | Charged particle beam injection method and apparatus used in conjunction with a charged particle cancer therapy system |
WO2009142547A2 (en) | 2008-05-22 | 2009-11-26 | Vladimir Yegorovich Balakin | Charged particle beam acceleration method and apparatus as part of a charged particle cancer therapy system |
US8901509B2 (en) | 2008-05-22 | 2014-12-02 | Vladimir Yegorovich Balakin | Multi-axis charged particle cancer therapy method and apparatus |
NZ589387A (en) | 2008-05-22 | 2012-11-30 | Vladimir Yegorovich Balakin | Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system |
EP2283710B1 (en) | 2008-05-22 | 2018-07-11 | Vladimir Yegorovich Balakin | Multi-field charged particle cancer therapy apparatus |
KR101316438B1 (ko) | 2009-03-04 | 2013-10-08 | 자크리토에 악치오네르노에 오브쉐스트보 프로톰 | 다중-필드 하전 입자 암 치료 방법 및 장치 |
US8609097B2 (en) * | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
AU2012322762B2 (en) * | 2011-10-14 | 2018-03-08 | Assistance Publique-Hospitaux De PAris | Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
CN112426434A (zh) * | 2020-11-04 | 2021-03-02 | 山东大学 | 硫酸乙酰肝素在防治阿尔兹海默症中的应用 |
CN114478816A (zh) * | 2022-02-11 | 2022-05-13 | 上海兴糖生物技术有限公司 | 一种白玉蜗牛多糖及其制备方法和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4351938A (en) * | 1980-05-19 | 1982-09-28 | Riker Laboratories, Inc. | Anticoagulant substance |
US4847338A (en) * | 1985-03-28 | 1989-07-11 | University Of Iowa Research Foundation | Low molecular weight heparin fragments as inhibitors of complement activation |
EP0243974B1 (en) * | 1986-05-01 | 1994-03-02 | Toppan Printing Co., Ltd. | Scanner set-up simulation apparatus |
IT1213384B (it) * | 1986-11-24 | 1989-12-20 | Lab Derivati Organici Mediolan | Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare. |
IT1205042B (it) * | 1987-05-28 | 1989-03-10 | Crinos Industria Farmaco | Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer |
EP0337327A1 (en) * | 1988-04-09 | 1989-10-18 | Bioiberica, S.A. | Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin |
IT1240615B (it) * | 1990-04-03 | 1993-12-17 | Mediolanum Farmaceutici Spa | Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale |
-
1999
- 1999-05-14 IT IT1999MI001066A patent/IT1312107B1/it active
-
2000
- 2000-05-12 ES ES00925281T patent/ES2237425T3/es not_active Expired - Lifetime
- 2000-05-12 JP JP2000617903A patent/JP2002544233A/ja active Pending
- 2000-05-12 AU AU44052/00A patent/AU764743C/en not_active Ceased
- 2000-05-12 HU HU0201100A patent/HUP0201100A3/hu unknown
- 2000-05-12 CZ CZ20014092A patent/CZ20014092A3/cs unknown
- 2000-05-12 US US10/048,542 patent/US6979680B1/en not_active Expired - Fee Related
- 2000-05-12 CA CA002373975A patent/CA2373975A1/en not_active Abandoned
- 2000-05-12 PL PL352070A patent/PL198016B1/pl not_active IP Right Cessation
- 2000-05-12 AT AT00925281T patent/ATE288761T1/de not_active IP Right Cessation
- 2000-05-12 KR KR1020017014505A patent/KR100711142B1/ko not_active IP Right Cessation
- 2000-05-12 DK DK00925281T patent/DK1181024T3/da active
- 2000-05-12 WO PCT/EP2000/004311 patent/WO2000069444A1/en active IP Right Grant
- 2000-05-12 PT PT00925281T patent/PT1181024E/pt unknown
- 2000-05-12 DE DE60018061T patent/DE60018061T2/de not_active Expired - Fee Related
- 2000-05-12 IL IL14645800A patent/IL146458A0/xx not_active IP Right Cessation
- 2000-05-12 CN CNB00807562XA patent/CN1178667C/zh not_active Expired - Fee Related
- 2000-05-12 EP EP00925281A patent/EP1181024B1/en not_active Expired - Lifetime
- 2000-05-12 RU RU2001130882/14A patent/RU2248800C2/ru not_active IP Right Cessation
-
2001
- 2001-11-13 ZA ZA200109331A patent/ZA200109331B/xx unknown
- 2001-11-13 NO NO20015544A patent/NO328902B1/no not_active IP Right Cessation
-
2002
- 2002-02-28 HK HK02101550.8A patent/HK1039903B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1312107B1 (it) | 2002-04-04 |
JP2002544233A (ja) | 2002-12-24 |
NO20015544D0 (no) | 2001-11-13 |
AU4405200A (en) | 2000-12-05 |
ES2237425T3 (es) | 2005-08-01 |
RU2248800C2 (ru) | 2005-03-27 |
ITMI991066A1 (it) | 2000-11-14 |
HK1039903B (zh) | 2005-08-26 |
PT1181024E (pt) | 2005-06-30 |
ATE288761T1 (de) | 2005-02-15 |
EP1181024A1 (en) | 2002-02-27 |
DE60018061D1 (de) | 2005-03-17 |
HUP0201100A2 (hu) | 2002-07-29 |
HK1039903A1 (en) | 2002-05-17 |
NO20015544L (no) | 2002-01-14 |
KR100711142B1 (ko) | 2007-04-24 |
KR20020005033A (ko) | 2002-01-16 |
PL352070A1 (en) | 2003-07-28 |
AU764743C (en) | 2004-03-18 |
HUP0201100A3 (en) | 2003-03-28 |
DK1181024T3 (da) | 2005-06-13 |
CN1350459A (zh) | 2002-05-22 |
CA2373975A1 (en) | 2000-11-23 |
US6979680B1 (en) | 2005-12-27 |
EP1181024B1 (en) | 2005-02-09 |
NO328902B1 (no) | 2010-06-14 |
WO2000069444A1 (en) | 2000-11-23 |
DE60018061T2 (de) | 2006-04-13 |
AU764743B2 (en) | 2003-08-28 |
PL198016B1 (pl) | 2008-05-30 |
CZ20014092A3 (cs) | 2002-04-17 |
CN1178667C (zh) | 2004-12-08 |
ZA200109331B (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200109331B (en) | Glycosaminoglycans having an average molecular weight equal to 2400 D suitable for the treatment of senile dementia. | |
CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
WO2003053330A3 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 | |
HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
CA2171882A1 (en) | Inhibitors of .beta.-amyloid protein production | |
UA48946C2 (uk) | Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування | |
WO2000047568A3 (en) | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases | |
CA2343236A1 (en) | 4,4-biarylpiperidine derivatives | |
CA2392879A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
AU1947895A (en) | Sublingual or buccal pharmaceutical composition | |
MD1838G2 (ro) | Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice | |
AU2365701A (en) | Use of hymenialdisine or derivatives thereof in the manufacture of medicaments | |
AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
CA2233315A1 (en) | Pharmaceutical compositions containing hydroximic acid derivatives | |
CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
AU2002359162A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
AU3083899A (en) | (in vitro) formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases | |
PL346143A1 (en) | Tan-1057 derivatives | |
CA2217513A1 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
UA42731C2 (uk) | Арилалкілтіадіазинони, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб лікування | |
HK61897A (en) | New derivatives of physostigmine their use and pharmaceutical formulations containing them | |
WO2001083449A3 (en) | Rigid pyrrolidone modulators of pkc | |
AU2001294310A1 (en) | Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them | |
WO1999021005A3 (en) | Pharmaceutical grade st. john's wort |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |